Metrics to relate COVID-19 wastewater data to clinical testing dynamics
- PMID: 35101695
- PMCID: PMC8758950
- DOI: 10.1016/j.watres.2022.118070
Metrics to relate COVID-19 wastewater data to clinical testing dynamics
Abstract
Wastewater surveillance has emerged as a useful tool in the public health response to the COVID-19 pandemic. While wastewater surveillance has been applied at various scales to monitor population-level COVID-19 dynamics, there is a need for quantitative metrics to interpret wastewater data in the context of public health trends. 24-hour composite wastewater samples were collected from March 2020 through May 2021 from a Massachusetts wastewater treatment plant and SARS-CoV-2 RNA concentrations were measured using RT-qPCR. The relationship between wastewater copy numbers of SARS-CoV-2 gene fragments and COVID-19 clinical cases and deaths varies over time. We demonstrate the utility of three new metrics to monitor changes in COVID-19 epidemiology: (1) the ratio between wastewater copy numbers of SARS-CoV-2 gene fragments and clinical cases (WC ratio), (2) the time lag between wastewater and clinical reporting, and (3) a transfer function between the wastewater and clinical case curves. The WC ratio increases after key events, providing insight into the balance between disease spread and public health response. Time lag and transfer function analysis showed that wastewater data preceded clinically reported cases in the first wave of the pandemic but did not serve as a leading indicator in the second wave, likely due to increased testing capacity, which allows for more timely case detection and reporting. These three metrics could help further integrate wastewater surveillance into the public health response to the COVID-19 pandemic and future pandemics.
Keywords: SARS-CoV-2; Temporal dynamics; Wastewater surveillance; Wastewater-based epidemiology.
Copyright © 2022. Published by Elsevier Ltd.
Conflict of interest statement
MM and NG are cofounders of Biobot Analytics. EJA, TBE, PRC, and WPH are advisors to Biobot Analytics. CD, NE, MI, and KAM are employees at Biobot Analytics, and all these authors hold shares in the company.
Figures
Update of
-
Metrics to relate COVID-19 wastewater data to clinical testing dynamics.medRxiv [Preprint]. 2021 Jun 16:2021.06.10.21258580. doi: 10.1101/2021.06.10.21258580. medRxiv. 2021. Update in: Water Res. 2022 Apr 1;212:118070. doi: 10.1016/j.watres.2022.118070. PMID: 34159339 Free PMC article. Updated. Preprint.
References
-
- Ahmed W., Angel N., Edson J., Bibby K., Bivins A., O'Brien J.W., Choi P.M., Kitajima M., Simpson S.L., Li J., Tscharke B., Verhagen R., Smith W.J.M., Zaugg J., Dierens L., Hugenholtz P., Thomas K.V., Mueller J.F. First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: a proof of concept for the wastewater surveillance of COVID-19 in the community. Sci. Total Environ. 2020;728 doi: 10.1016/j.scitotenv.2020.138764. - DOI - PMC - PubMed
-
- Baker, C.D., 2021a. Order advancing all communities to Phase III, Step 2 of the Commonwealth's reopening plan. Commonwealth of Massachusetts Office of the Governor.
-
- Baker, C.D., 2021b. Order advancing all communities to Phase IV, Step 1 of the Commonwealth's reopening plan and transitioning to a travel advisory policy. Commonwealth of Massachusetts Office of the Governor.
-
- Baker, C.D., 2020a. Order implementing a phased reopening of workplaces and imposing workplace safety measures to address COVID-19. Commonwealth of Massachusetts Office of the Governor.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
